Published in Reprod Biol Endocrinol on September 10, 2014
The N14 anti-afamin antibody Fab: a rare VL1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling. Acta Crystallogr D Struct Biol (2016) 0.77
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 12.27
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol (2007) 7.79
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care (2005) 7.05
Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care (2004) 6.68
Clinical assessment of body hair growth in women. J Clin Endocrinol Metab (1961) 6.01
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med (2006) 4.69
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes (1989) 3.74
The metabolic syndrome. Lancet (2010) 3.47
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 2.52
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev (2003) 1.69
Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol (2013) 1.60
Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes (2006) 1.49
Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.35
Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem (1994) 1.28
Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol (2005) 1.25
Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab (1997) 1.21
Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res (2005) 1.13
The role of genes and environment in the etiology of PCOS. Endocrine (2006) 1.05
Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry (2002) 1.05
Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ Cardiovasc Genet (2014) 0.84
Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta (2013) 0.83
Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations. Gynecol Endocrinol (2013) 0.82
Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol (2012) 0.81
Type 2 diabetes and polycystic ovary syndrome. Fertil Steril (2006) 0.81
Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome. Endocr Connect (2014) 0.77
An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia. Clin Endocrinol (Oxf) (1980) 0.76
An advanced method in fetal phonocardiography. Comput Methods Programs Biomed (2003) 1.43
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial. Eur J Obstet Gynecol Reprod Biol (2009) 1.18
Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev (2005) 1.11
Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril (2003) 1.01
Association of progesterone receptor polymorphism with recurrent abortions. Eur J Obstet Gynecol Reprod Biol (2004) 0.99
Adenomyosis and reproduction. Best Pract Res Clin Obstet Gynaecol (2006) 0.94
Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system. Contraception (2012) 0.89
Uterine peristaltic activity and the development of endometriosis. Ann N Y Acad Sci (2004) 0.87
Simultaneous online SPE-LC-MS/MS quantification of six widely used synthetic progestins in human plasma. Anal Bioanal Chem (2011) 0.86
Comparison of GnRH agonists and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matched study. Eur J Obstet Gynecol Reprod Biol (2002) 0.85
In vitro bioactivity of 17alpha-estradiol. J Steroid Biochem Mol Biol (2004) 0.85
Estrogenic effects of natural and synthetic compounds including tibolone assessed in Saccharomyces cerevisiae expressing the human estrogen alpha and beta receptors. FASEB J (2006) 0.84
Intrauterine microdialysis reveals cycle-dependent regulation of endometrial insulin-like growth factor binding protein-1 secretion by human chorionic gonadotropin. Fertil Steril (2002) 0.83
Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta (2013) 0.83
Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations. Gynecol Endocrinol (2013) 0.82
Tissue perfusion-controlled guided biopsies are essential for the outcome of testicular sperm extraction. Fertil Steril (2006) 0.81
The vitamin E-binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis. Fertil Steril (2010) 0.81
Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome. Fertil Steril (2010) 0.81
Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis. Ann N Y Acad Sci (2007) 0.80
A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Horm Mol Biol Clin Investig (2011) 0.80
Female fertility after cytotoxic therapy--protection of ovarian function during chemotherapy of malignant and non-malignant diseases. Eur J Haematol Suppl (2005) 0.79
Cycle dependency of intrauterine vascular endothelial growth factor levels is correlated with decidualization and corpus luteum function. Fertil Steril (2003) 0.78
Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice. Arch Gynecol Obstet (2013) 0.78
Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women. Fertil Steril (2006) 0.78
Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab (2010) 0.78
Dynamics of anti-Müllerian hormone during controlled ovarian stimulation. Gynecol Endocrinol (2013) 0.78
Membrane initiated steroid signaling (MISS): computational, in vitro and in vivo evidence for a plasma membrane protein initially involved in genomic steroid hormone effects. Mol Cell Endocrinol (2006) 0.77
Spontaneous normalization of ovarian function and pregnancy in a patient with resistant ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2003) 0.77
Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea. Fertil Steril (2007) 0.77
Effects of levetiracetam and valproic acid monotherapy on sex-steroid hormones in prepubertal children--results from a pilot study. Epilepsy Res (2009) 0.77
Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects. Reprod Biol Endocrinol (2014) 0.76
Verification bias? Fertil Steril (2007) 0.75
Use of the levonorgestrel-releasing intrauterine system: an Austrian perspective. Curr Opin Obstet Gynecol (2009) 0.75
Oxytocin plasma levels in psychiatric patients with and without recent suicide attempt. Psychiatry Res (2012) 0.75
Tubal transport of spermatozoa does not appear to be dependent on normal cilia function. Fertil Steril (2007) 0.75
An ultra-sensitive online SPE-LC-MS/MS method for the quantification of levonorgestrel released from intrauterine devices. Anal Bioanal Chem (2011) 0.75
NSCLC without Antineoplastic Treatment: Incidence, Characteristics, and Outcome as Outlined in the TYROL Study. Oncology (2015) 0.75
The biphasic pattern of end-expiratory carbon dioxide pressure: a method for identification of the fertile phase of the menstrual cycle. Fertil Steril (2007) 0.75
Symptoms of premenstrual syndrome may be caused by hyperventilation. Fertil Steril (2006) 0.75
Reproductive Bioengineering 2008. Introduction. Eur J Obstet Gynecol Reprod Biol (2009) 0.75